Sahlgrenska University Hospital-Vastra Gotalandsregionen
Sahlgrenska University Hospital-Vastra Gotalandsregionen is recorded as a service provider in 4 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 4 of 4 trials · Latest update first
LBL 2018 – International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma
Sponsor Universitaetsklinikum Muenster AöR
- Start (EU)
- Latest update
- Estimated end
A randomised double-blind placebo-controlled clinical trial investigating the effect and safety of oral semaglutide in subjects with early Alzheimer´s disease (EVOKE plus)
Sponsor Novo Nordisk A/S
- Start (EU)
- Latest update
- Estimated end
Operational learnings available2 trial-level findings · Read insights
- The trial was conducted at 380 sites in 38 countries.
- Early termination meant that many participants did not have the opportunity to reach week 156, and available week-156 data did not represent the prespecified planned outcome evaluation.
These findings describe the trial, not the service provider’s performance or responsibility.
A randomised double-blind placebo-controlled clinical trial investigating the effect and safety of oral semaglutide in subjects with early Alzheimer´s disease (EVOKE)
Sponsor Novo Nordisk A/S
- Start (EU)
- Latest update
- Estimated end
Operational learnings available2 trial-level findings · Read insights
- The study was conducted at 341 sites in 37 countries.
- Because of early termination, many participants did not have the opportunity to reach week 156, so the available long-term data did not represent the prespecified outcome evaluation.
These findings describe the trial, not the service provider’s performance or responsibility.
A randomised double-blind placebo-controlled clinical study investigating the effects of semaglutide s.c. once-weekly versus placebo on central and peripheral inflammation in participants with Alzheimer’s disease.
Sponsor Novo Nordisk A/S
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Sahlgrenska University Hospital-Vastra Gotalandsregionen?
The 2026-10-09 snapshot links Sahlgrenska University Hospital-Vastra Gotalandsregionen to 4 distinct CTIS trials. Recorded services include Laboratory services, Reference pathology for the Nordic Countries. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Sahlgrenska University Hospital-Vastra Gotalandsregionen?
The most frequently recorded therapeutic areas are Neurology, Haematological Malignancies. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Sahlgrenska University Hospital-Vastra Gotalandsregionen conducted?
The linked trials record locations in 22 countries, including Denmark, Sweden, Austria, Belgium, Czechia. These are trial locations, not confirmed office locations or countries where Sahlgrenska University Hospital-Vastra Gotalandsregionen delivered services.
What can this page tell me about Sahlgrenska University Hospital-Vastra Gotalandsregionen's trial experience?
Browse 4 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. 2 trials have operational findings that can inform further due diligence. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Sahlgrenska University Hospital-Vastra Gotalandsregionen. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Sahlgrenska University Hospital-Vastra Gotalandsregionen